Skip to main content

Table 2 Energy and macronutrients intake in the intervention and control groups before and after the intervention

From: The effects of flaxseed supplementation on metabolic status in women with polycystic ovary syndrome: a randomized open-labeled controlled clinical trial

Variable

Flaxseed group (n = 21)

Control group (n = 20)

P1-value

Energy (kcal)

 Before

1935.27 ± 488.7

1679.99 ± 316

0.093

 After

1868.52 ± 462.86

1700.22 ± 313.41

0.168

 P2-value

0.097

0.582

 

Carbohydrate (g)

 Before

272.37 ± 68.83

234.89 ± 59.27

0.131

 After

249.29 ± 70.95

242.60 ± 49.03

0.720

 P2-value

0.006

0.274

 

Protein (g)

 Before

84.39 ± 75.93

72.99 ± 22.86

0.179

 After

60.93 ± 14.96

62.09 ± 14.69

0.073

 P2-value

0.179

0.705

 

Fat (g)

 Before

62.72 ± 18.57

54.46 ± 11.94

0.097

 After

63.27 ± 19.68

56.65 ± 13.83

0.208

 P2-value

0.865

0.378

 

PUFA (g)

 Before

16.33 ± 6.03

14.73 ± 3.91

0.338

 After

16.46 ± 5.32

15.19 ± 2.91

0.343

 P2-value

0.849

0.471

 

MUFA (g)

 Before

23.24 ± 6.57

19.84 ± 4.7

0.054

 After

23.88 ± 6.62

20.53 ± 5.93

0.088

 P2-value

0.620

0.552

 

SFA (g)

 Before

17.7 ± 9.15

15.48 ± 5.6

0.397

 After

16.89 ± 7.58

16.14 ± 6.38

0.725

 P2-value

0.591

0.499

 
  1. SFA, saturated fatty acid; PUFA, polyunsaturated fatty acid; MUFA, monounsaturated fatty acids. The data have been expressed as mean ± SD. P1: between-group comparison of the variables; independent sample t-test (for energy and dietary protein, fat, PUFA, MUFA, and SFA) and Mann–Whitney U test (for dietary carbohydrate). P2: within-group comparison of the variables; paired sample t-test (for energy and dietary protein, fat, PUFA, MUFA, and SFA intake) and Wilcoxon signed-rank test (for dietary carbohydrate)